ddo-3055
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 25, 2019 (NCT03976115)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
O=C(O)CNC(=O)c1ncc(C#CCOc2ccc(Cl)cc2)cc1O- Mol. weight
- 360.75 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4162752 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04775615 | Phase 1 | Mar 17, 2021 | Hengrui Therapeutics, Inc. |
| NCT04470063 | Phase 1 | Jul 31, 2020 | Hengrui Therapeutics, Inc. |
| NCT04197778 | Phase 1 | Dec 31, 2019 | Hengrui Therapeutics, Inc. |
| NCT03976115 | Phase 1 | Jun 25, 2019 | Hengrui Therapeutics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 4 | 4 | 1 | 2019 |
1 organizations
Page 1 / 1